This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1983 Jun;35(6):631-4.

doi: 10.1097/00007890-198306000-00024.

In vivo administration of Interleukin-2 enhances specific alloimmune responses

S A Rosenberg, P J Spiess, S Schwarz

PMID: 6603037
DOI: 10.1097/00007890-198306000-00024

In vivo administration of Interleukin-2 enhances specific alloimmune responses

S A Rosenberg et al. Transplantation. 1983 Jun.

. 1983 Jun;35(6):631-4.

doi: 10.1097/00007890-198306000-00024.

Authors

S A Rosenberg, P J Spiess, S Schwarz

PMID: 6603037
DOI: 10.1097/00007890-198306000-00024

No abstract available

PubMed Disclaimer

Similar articles

Coexpression of IL-2 and gamma-IFN enhances tumor immunity.
McAdam A, Pulaski B, Harkins S, Hutter E, Frelinger J, Lord E. McAdam A, et al. Ann N Y Acad Sci. 1993 Aug 12;690:349-51. doi: 10.1111/j.1749-6632.1993.tb44027.x. Ann N Y Acad Sci. 1993. PMID: 8368753 No abstract available.
The optimal activation of cytotoxic T lymphocytes requires metabolically intact stimulator cells not only for the activation of the interleukin 2-producing helper cells.
Dröge W, Männel D, Falk W, Schmidt H, Panknin S, Dotterer W. Dröge W, et al. J Immunol. 1983 Jul;131(1):520-8. J Immunol. 1983. PMID: 6223082 No abstract available.
Synergy of OK-432 and recombinant interleukin 2 in the antitumor immunity induction and the cytotoxic T-lymphocyte generation.
Ujiie T. Ujiie T. Jpn J Exp Med. 1990 Jun;60(3):85-92. Jpn J Exp Med. 1990. PMID: 2214256 No abstract available.
Regulation of the immune response T-cell interactions.
Dutton RW, Swain SL. Dutton RW, et al. CRC Crit Rev Immunol. 1982 Feb;3(3):209-61. CRC Crit Rev Immunol. 1982. PMID: 6176399 Review. No abstract available.
Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
Boon T, Coulie P, Marchand M, Weynants P, Wölfel T, Brichard V. Boon T, et al. Important Adv Oncol. 1994:53-69. Important Adv Oncol. 1994. PMID: 8206495 Review. No abstract available.

See all similar articles

Cited by

Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response.
McCulloch P, Gallagher G, Walsh LP, Zaloom Y, Xie J. McCulloch P, et al. Clin Exp Immunol. 1991 Sep;85(3):519-24. doi: 10.1111/j.1365-2249.1991.tb05760.x. Clin Exp Immunol. 1991. PMID: 1893635 Free PMC article.
The toxicity of recombinant human interleukin-2 in rats following intravenous infusion.
Matory YL, Chang AE, Lipford EH 3rd, Braziel R, Hyatt CL, Rosenberg SA. Matory YL, et al. J Natl Med Assoc. 1987 May;79(5):537-41. J Natl Med Assoc. 1987. PMID: 3495666 Free PMC article.
Effect of interleukin-2 on the manifestation and growth of acetoxymethyl-methylnitrosamine-induced colorectal rat adenocarcinoma.
Garzon FT, Salas M, Berger MR, Kirchner H. Garzon FT, et al. J Cancer Res Clin Oncol. 1986;111(1):79-81. doi: 10.1007/BF00402782. J Cancer Res Clin Oncol. 1986. PMID: 3485102 Free PMC article.
Recruitment of inflammatory cells to a tumor deposit potentiates the immunotherapeutic effects of interleukin-2.
Steller EP, Eggermont AM, Matthews W, Sugarbaker PH. Steller EP, et al. Cancer Immunol Immunother. 1986;23(3):165-8. doi: 10.1007/BF00205645. Cancer Immunol Immunother. 1986. PMID: 3491680 Free PMC article.
Enhancement of a delayed hypersensitivity reaction to a contact allergen, by the systemic administration of interleukin-2.
Zaloom Y, Walsh LP, McCulloch P, Gallagher G. Zaloom Y, et al. Immunology. 1991 Apr;72(4):584-7. Immunology. 1991. PMID: 2037319 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database